Completed
Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
NCT03194776
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
- Locations
-
- Novartis Investigative Site Jacksonville, Florida, United States
- Novartis Investigative Site Columbus, Ohio, United States
- Novartis Investigative Site Kiel, Schleswig-Holstein, Germany
- Novartis Investigative Site Berlin, Germany